Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab in RA with Inadequate Response to Methotrexate
NCT00611455Phase 3Terminated
- Sponsor
- GSK
- Start
- Jan 2008
- Primary completion
- Jun 2009
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 3 trial of ofatumumab in rheumatoid arthritis (RA), sponsored by GSK. Started Jan 2008; status: terminated.
02
Drugs
ofatumumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00611455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611455.